JP2006523437A5 - - Google Patents

Download PDF

Info

Publication number
JP2006523437A5
JP2006523437A5 JP2004570696A JP2004570696A JP2006523437A5 JP 2006523437 A5 JP2006523437 A5 JP 2006523437A5 JP 2004570696 A JP2004570696 A JP 2004570696A JP 2004570696 A JP2004570696 A JP 2004570696A JP 2006523437 A5 JP2006523437 A5 JP 2006523437A5
Authority
JP
Japan
Prior art keywords
tcr
complex according
chain
polypeptide
tcr complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004570696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006523437A (ja
Filing date
Publication date
Priority claimed from GB0228112A external-priority patent/GB0228112D0/en
Priority claimed from GB0304090A external-priority patent/GB0304090D0/en
Priority claimed from GB0308309A external-priority patent/GB0308309D0/en
Priority claimed from GB0314113A external-priority patent/GB0314113D0/en
Priority claimed from GB0316354A external-priority patent/GB0316354D0/en
Application filed filed Critical
Priority claimed from PCT/GB2003/005104 external-priority patent/WO2004050705A2/en
Publication of JP2006523437A publication Critical patent/JP2006523437A/ja
Publication of JP2006523437A5 publication Critical patent/JP2006523437A5/ja
Withdrawn legal-status Critical Current

Links

JP2004570696A 2002-12-03 2003-11-25 レセプター複合体 Withdrawn JP2006523437A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0228112A GB0228112D0 (en) 2002-12-03 2002-12-03 Receptors
GB0304090A GB0304090D0 (en) 2003-02-22 2003-02-22 Receptors
GB0308309A GB0308309D0 (en) 2003-04-10 2003-04-10 Receptors
US47590603P 2003-06-05 2003-06-05
GB0314113A GB0314113D0 (en) 2003-06-18 2003-06-18 Receptors
GB0316354A GB0316354D0 (en) 2003-07-11 2003-07-11 Receptors
PCT/GB2003/005104 WO2004050705A2 (en) 2002-12-03 2003-11-25 Complexes of receptors

Publications (2)

Publication Number Publication Date
JP2006523437A JP2006523437A (ja) 2006-10-19
JP2006523437A5 true JP2006523437A5 (https=) 2006-12-14

Family

ID=32475869

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004570696A Withdrawn JP2006523437A (ja) 2002-12-03 2003-11-25 レセプター複合体

Country Status (5)

Country Link
US (1) US20060135418A1 (https=)
EP (1) EP1567553A2 (https=)
JP (1) JP2006523437A (https=)
AU (1) AU2003286263A1 (https=)
WO (1) WO2004050705A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101131297B1 (ko) * 2003-11-10 2012-03-30 알토 바이오사이언스 코포레이션 가용성 티씨알 분자 및 이용 방법
US20060116824A1 (en) * 2004-12-01 2006-06-01 Ishikawa Muriel Y System and method for modulating a humoral immune response
US20060047433A1 (en) * 2004-08-24 2006-03-02 Ishikawa Muriel Y System and method related to enhancing an immune system
US20060095211A1 (en) * 2003-12-05 2006-05-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System and method for modulating a cell mediated immune response
US20060047437A1 (en) * 2004-08-25 2006-03-02 Ishikawa Muriel Y System and method for heightening an immune response
US20060047436A1 (en) * 2004-08-25 2006-03-02 Ishikawa Muriel Y System and method for magnifying an immune response
US20060122784A1 (en) * 2004-12-03 2006-06-08 Ishikawa Muriel Y System and method for augmenting a humoral immune response
US20060182742A1 (en) * 2004-08-24 2006-08-17 Ishikawa Muriel Y System and method for magnifying a humoral immune response
US20060047434A1 (en) * 2004-08-24 2006-03-02 Ishikawa Muriel Y System and method related to improving an immune system
US20060122783A1 (en) * 2004-08-24 2006-06-08 Ishikawa Muriel Y System and method for heightening a humoral immune response
US20060047435A1 (en) * 2004-08-24 2006-03-02 Ishikawa Muriel Y System and method related to augmenting an immune system
US20070265818A1 (en) * 2004-08-24 2007-11-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems for heightening cell-mediated immune response
US20070196362A1 (en) * 2004-08-24 2007-08-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems to bolster an immune response
US20060047439A1 (en) * 2004-08-24 2006-03-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System and method for improving a humoral immune response
US20070198196A1 (en) * 2004-08-24 2007-08-23 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods relating to ameliorating an immune system
US20070265819A1 (en) * 2004-08-24 2007-11-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems for improving cell-mediated immune response
US20070207492A1 (en) * 2004-08-24 2007-09-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems to adjust a humoral immune response
JP2008514685A (ja) * 2004-10-01 2008-05-08 メディジーン リミテッド 治療剤に連結した、非天然型ジスルフィド鎖間結合を含有するt細胞レセプター
GB0427585D0 (en) * 2004-12-16 2005-01-19 Avidex Ltd Assay
EP1699826B1 (en) 2005-01-05 2009-03-11 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions
GB0511124D0 (en) * 2005-06-01 2005-07-06 Avidex Ltd High affinity melan-a t cell receptors
WO2007073147A1 (en) * 2005-12-20 2007-06-28 Erasmus University Medical Center Rotterdam Apoptosis-inducing protein complexes and therapeutic use thereof
EP1870418A1 (en) 2006-06-20 2007-12-26 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Allorestricted peptide-specific T cells
AT503889B1 (de) 2006-07-05 2011-12-15 Star Biotechnologische Forschungs Und Entwicklungsges M B H F Multivalente immunglobuline
AT503861B1 (de) 2006-07-05 2008-06-15 F Star Biotech Forsch & Entw Verfahren zur manipulation von t-zell-rezeptoren
US8088379B2 (en) 2006-09-26 2012-01-03 The United States Of America As Represented By The Department Of Health And Human Services Modified T cell receptors and related materials and methods
ES2627223T3 (es) 2007-06-26 2017-07-27 F-Star Biotechnologische Forschungs- Und Entwicklungsges.M.B.H Presentación de agentes de unión
GB0712670D0 (en) 2007-06-29 2007-08-08 King S College London Isolated peptides and uses thereof
EP2113255A1 (en) 2008-05-02 2009-11-04 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Cytotoxic immunoglobulin
GB0816096D0 (en) * 2008-09-04 2008-10-15 Medigene Ltd Diabetes t cell receptors
CA2822938A1 (en) * 2010-12-27 2012-07-05 Apo-T B.V. A polypeptide that binds aberrant cells and induces apoptosis
WO2012091564A2 (en) 2010-12-27 2012-07-05 Apo-T B.V. A cross-linking polypeptide that induces apoptosis
WO2013048243A1 (en) 2011-09-29 2013-04-04 Apo-T B.V. Multi-specific binding molecules targeting aberrant cells
CA2860914A1 (en) 2012-01-13 2013-07-18 Apo-T B.V. Aberrant cell-restricted immunoglobulins provided with a toxic moiety
CN106279404A (zh) * 2015-05-20 2017-01-04 广州市香雪制药股份有限公司 一种可溶且稳定的异质二聚tcr
JP2020501508A (ja) * 2016-09-15 2020-01-23 クアドルセプト バイオ リミテッド 多量体、四量体および八量体
WO2020018715A1 (en) 2018-07-17 2020-01-23 Massachusetts Institute Of Technology Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625275A (en) * 1984-04-03 1986-11-25 Republic Money Orders, Inc. Apparatus for dispensing money orders
NZ331688A (en) * 1996-03-28 2000-02-28 Univ Johns Hopkins Soluble divalent and multivalent heterodimeric analogs of proteins
US6211342B1 (en) * 1996-07-18 2001-04-03 Children's Hospital Medical Center Multivalent MHC complex peptide fusion protein complex for stimulating specific T cell function
WO1998039482A1 (en) * 1997-03-07 1998-09-11 Sunol Molecular Corporation Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
WO1999060120A2 (en) * 1998-05-19 1999-11-25 Avidex Limited Soluble t cell receptor
DE69936927T2 (de) * 1998-10-21 2008-05-15 Altor Bioscience Corp., Miramar Polyspezifische bindemoleküle und deren verwendung
EP1259601A2 (en) * 2000-02-22 2002-11-27 Ahuva Nissim Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
AU7524601A (en) * 2000-06-05 2001-12-17 Sunol Molecular Corp T cell receptor fusions and conjugates and methods of use thereof
US6811785B2 (en) * 2001-05-07 2004-11-02 Mount Sinai School Of Medicine Of New York University Multivalent MHC class II—peptide chimeras

Similar Documents

Publication Publication Date Title
JP2006523437A5 (https=)
JP6710253B2 (ja) Apj受容体アゴニストおよびその使用
ES2950789T3 (es) Polipéptidos de apelina
JP2006502741A5 (https=)
LeBerthon et al. Enhanced tumor uptake of macromolecules induced by a novel vasoactive interleukin 2 immunoconjugate
JP2021502810A5 (https=)
JP2004248677A5 (https=)
JP2007526330A5 (https=)
WO2004050705A3 (en) Complexes of receptors
JP2012504965A5 (https=)
JP2011501951A5 (https=)
JP2010534486A5 (https=)
JP2012521201A5 (https=)
MXPA04008419A (es) Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos.
PE20091405A1 (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
JP2008535826A5 (https=)
JP2007536933A5 (https=)
JP2020509737A5 (https=)
JP2019530441A5 (https=)
JP2020532496A5 (https=)
JP2010524968A5 (https=)
Rizvi et al. Engineering peptide drug therapeutics through chemical conjugation and implication in clinics
JP2006517970A5 (https=)
TR200001961T2 (tr) Ifnar 2/IFN kompleksi.
JP2018521977A5 (https=)